CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors Dilated cardiomyopathy: so many cardiomyopathies! The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus Optical coherence tomography and intravascular ultrasound assessment of the anatomic size and wall thickness of a muscle bridge segment A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling Contemporary real-world outcomes of surgical aortic valve replacement in 141,905 low-risk, intermediate-risk, and high-risk patients The Objective Physical Activity and Cardiovascular Disease Health in Older Women (OPACH) Study Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association Circadian-Regulated Cell Death in Cardiovascular Diseases

Original Research2017 Nov 1;38(41):3056-3065.

JOURNAL:Eur Heart J. Article Link

Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014

Szummer K, Wallentin L, Lindhagen L et al. Keywords: Registry, Myocardial infarction, Time-trends, Outcomes

FULL TEXT PDF